fda testosterone

  1. Nelson Vergel

    The FDA to meet on Sept 17, 2014 to discuss testosterone risks

    By Reuters Staff The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy. The FDA has called for a joint meeting of the bone, reproductive and urologic drugs...
Top